---
annotations:
- type: Pathway Ontology
  value: Fc epsilon receptor mediated signaling pathway
authors:
- ReactomeTeam
- Anwesha
- Mkutmon
description: Mast cells (MC) are distributed in tissues throughout the human body
  and have long been recognized as key cells of type I hypersensitivity reactions.
  They also play important roles in inflammatory and immediate allergic reactions.
  Activation through FCERI-bound antigen-specific IgE causes release of potent inflammatory
  mediators, such as histamine, proteases, chemotactic factors, cytokines and metabolites
  of arachidonic acid that act on the vasculature, smooth muscle, connective tissue,
  mucous glands and inflammatory cells (Borish & Joseph 1992, Amin 2012, Metcalfe
  et al. 1993). FCERI is a multimeric cell-surface receptor that binds the Fc fragment
  of IgE with high affinity. On mast cells and basophils FCERI exists as a tetrameric
  complex consisting of one alpha-chain, one beta-chain, and two disulfide-bonded
  gamma-chains, and on dendritic cells, Langerhans cells, macrophages, and eosinophils
  it exists as a trimeric complex with one alpha-chain and two disulfide-bonded gamma-chains
  (Wu 2011, Kraft & Kinet 2007). FCERI signaling in mast cells includes a network
  of signaling molecules and adaptor proteins. These molecules coordinate ultimately
  leading to effects on degranulation, eicosanoid production, and cytokine and chemokine
  production and cell migration and adhesion, growth and survival.<br>The first step
  in FCERI signaling is the phosphorylation of the tyrosine residues in the ITAM of
  both the beta and the gamma subunits of the FCERI by LYN, which is bound to the
  FCERI beta-chain. The phosphorylated ITAM then recruits the protein tyrosine kinase
  SYK (spleen tyrosine kinase) which then phosphorylates the adaptor protein LAT.
  Phosphorylated LAT (linker for activation of T cells) acts as a scaffolding protein
  and recruits other cytosolic adaptor molecules GRB2 (growth-factor-receptor-bound
  protein 2), GADS (GRB2-related adaptor protein), SHC (SRC homology 2 (SH2)-domain-containing
  transforming protein C) and SLP76 (SH2-domain-containing leukocyte protein of 76
  kDa), as well as the exchange factors and adaptor molecules VAV and SOS (son of
  sevenless homologue), and the signalling enzyme phospholipase C gamma1 (PLC-gamma1).
  Tyrosoine phosphorylation of enzymes and adaptors, including VAV, SHC GRB2 and SOS
  stimulate small GTPases such as RAC, RAS and RAF. These pathways lead to activation
  of the ERK, JNK and p38 MAP kinases, histamine release and cytokine production.
  FCERI activation also triggers the phosphorylation of PLC-gamma which upon membrane
  localisation hydrolyse PIP2 to form IP3 and 1,2-diacylglycerol (DAG) - second messengers
  that release Ca2+ from internal stores and activate PKC, respectively. Degranulation
  or histamine release follows the activation of PLC-gamma and protein kinase C (PKC)
  and the increased mobilization of calcium (Ca2+). Receptor aggregation also results
  in the phosphorylation of adaptor protein NTAL/LAT2 which then recruits GAB2. PI3K
  associates with phosphorylated GAB2 and catalyses the formation of PIP3 in the membrane,
  which attracts many PH domain proteins like BTK, PLC-gamma, AKT and PDK. PI3K mediated
  activation of AKT then regulate the mast cell proliferation, development and survival
  (Gu et al. 2001).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2454202
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP2759
- /instance/WP2759
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP2759.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Mast cells (MC) are distributed in tissues throughout the human body
    and have long been recognized as key cells of type I hypersensitivity reactions.
    They also play important roles in inflammatory and immediate allergic reactions.
    Activation through FCERI-bound antigen-specific IgE causes release of potent inflammatory
    mediators, such as histamine, proteases, chemotactic factors, cytokines and metabolites
    of arachidonic acid that act on the vasculature, smooth muscle, connective tissue,
    mucous glands and inflammatory cells (Borish & Joseph 1992, Amin 2012, Metcalfe
    et al. 1993). FCERI is a multimeric cell-surface receptor that binds the Fc fragment
    of IgE with high affinity. On mast cells and basophils FCERI exists as a tetrameric
    complex consisting of one alpha-chain, one beta-chain, and two disulfide-bonded
    gamma-chains, and on dendritic cells, Langerhans cells, macrophages, and eosinophils
    it exists as a trimeric complex with one alpha-chain and two disulfide-bonded
    gamma-chains (Wu 2011, Kraft & Kinet 2007). FCERI signaling in mast cells includes
    a network of signaling molecules and adaptor proteins. These molecules coordinate
    ultimately leading to effects on degranulation, eicosanoid production, and cytokine
    and chemokine production and cell migration and adhesion, growth and survival.<br>The
    first step in FCERI signaling is the phosphorylation of the tyrosine residues
    in the ITAM of both the beta and the gamma subunits of the FCERI by LYN, which
    is bound to the FCERI beta-chain. The phosphorylated ITAM then recruits the protein
    tyrosine kinase SYK (spleen tyrosine kinase) which then phosphorylates the adaptor
    protein LAT. Phosphorylated LAT (linker for activation of T cells) acts as a scaffolding
    protein and recruits other cytosolic adaptor molecules GRB2 (growth-factor-receptor-bound
    protein 2), GADS (GRB2-related adaptor protein), SHC (SRC homology 2 (SH2)-domain-containing
    transforming protein C) and SLP76 (SH2-domain-containing leukocyte protein of
    76 kDa), as well as the exchange factors and adaptor molecules VAV and SOS (son
    of sevenless homologue), and the signalling enzyme phospholipase C gamma1 (PLC-gamma1).
    Tyrosoine phosphorylation of enzymes and adaptors, including VAV, SHC GRB2 and
    SOS stimulate small GTPases such as RAC, RAS and RAF. These pathways lead to activation
    of the ERK, JNK and p38 MAP kinases, histamine release and cytokine production.
    FCERI activation also triggers the phosphorylation of PLC-gamma which upon membrane
    localisation hydrolyse PIP2 to form IP3 and 1,2-diacylglycerol (DAG) - second
    messengers that release Ca2+ from internal stores and activate PKC, respectively.
    Degranulation or histamine release follows the activation of PLC-gamma and protein
    kinase C (PKC) and the increased mobilization of calcium (Ca2+). Receptor aggregation
    also results in the phosphorylation of adaptor protein NTAL/LAT2 which then recruits
    GAB2. PI3K associates with phosphorylated GAB2 and catalyses the formation of
    PIP3 in the membrane, which attracts many PH domain proteins like BTK, PLC-gamma,
    AKT and PDK. PI3K mediated activation of AKT then regulate the mast cell proliferation,
    development and survival (Gu et al. 2001).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2454202
    Reactome].
  keywords:
  - 'Ig lambda chain V-I region NEW '
  - 'p-S144,T423-PAK1 '
  - 'Ig kappa chain V-III region POM '
  - 'PSMB4 '
  - 'p-13S-NFATC3 '
  - 'BCL10 '
  - 'GTP '
  - 'IGLV10-54(1-?) '
  - NFAT:CaN:CaM
  - Clustered
  - 'SKP1 '
  - 'p-S257,T261-MAP2K4 '
  - SYK
  - 'Ig heavy chain V-III region BRO '
  - 'Ig kappa chain V-I region Daudi '
  - IP3 receptor
  - 'p-S243-NFATC2 '
  - PDK1:PIP2,PIP3
  - CALM1
  - DAG:p-5Y-PKC-theta:CBM oligomer:oligo-K63-poly Ub-TRAF6:TAK1:TAB1:TAB2/3
  - 'IGHV(1-?) '
  - 'PSMA2 '
  - 'PSMD12 '
  - PAK dimer
  - 'PSMB7 '
  - 'GRB2-1 '
  - TEC,BTK,ITK,(TXK)
  - NFKB1(1-433):RELA
  - p21 RAS:GTP
  - 'ITPR1 '
  - 'p-14S-NFATC2 '
  - 'LCP2 '
  - 'p-Y180,Y512-ITK '
  - 'PIK3R1 '
  - 'Ub-48-UBA52(1-76) '
  - RasGRPs
  - 'p-Y452,Y476,Y584-GAB2 '
  - 'S-Farn-Me PalmS NRAS '
  - Ub-TRAF6 trimer
  - 'Ub-200-UBB(153-228) '
  - BCL10:MALT1
  - p-5Y-LAT:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:PIP3:p-VAV:RAC1-GTP:PAK
    dimer
  - 'Ig lambda chain V-II region BOH '
  - DAG:p-5Y-PKC-theta:CBM oligomer:oligo-K63-poly Ub-TRAF6
  - 'p-Y90,T219,T538,S676,S695-PRKCQ '
  - 'Zn2+ '
  - 'IGLC7 '
  - 'Ca2+ '
  - 'IGKV1-5(23-?) '
  - 'Ub-656-UBC(609-684) '
  - 'PSMB9 '
  - 'RASGRP4 '
  - 'p-S63,S73-JUN '
  - 'IGLV1-40(1-?) '
  - 'PSMD14 '
  - IkB(alpha):NF-kB
  - 'Ig heavy chain V-III region BUT '
  - 'Ig kappa chain V-II region Cum '
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:SLP76
  - DAGs
  - 'IGLV3-25(1-?) '
  - 'p-Y239,Y240,Y317-SHC1-2 '
  - FCERI:IgE
  - 'p-S552-CARD11 '
  - 'IGLV2-33(1-?) '
  - 'ITK '
  - 'PSMB5 '
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:SLP76:PLCG
  - 'IGLV8-61(1-?) '
  - 'p-Y512-ITK '
  - 'GDP '
  - 'TAB1 '
  - DAG:p-5Y-PKC-theta:p-S552,S645-CARMA1 oligomer
  - 'K63polyUb-TRAF6 '
  - 'K63polyUb-NEMO '
  - 'p-S141,T402-PAK2 '
  - 'MAPK9 '
  - 'Ub-124-UBB(77-152) '
  - 'GAB2 '
  - K48-Ub
  - 'Ig heavy chain V-III region WEA '
  - 'PKC-theta (open):'
  - DAG:p-5Y-PKC-theta:CBM oligomer:oligo-K63-poly Ub-TRAF6:activated TAK1 complex
  - 'MAPK8 '
  - aggregate
  - 'IGLV3-22(1-?) '
  - 'IGLV7-46(1-?) '
  - p-Y396-LYN
  - p-S32,36-IkB-alpha:NF-kB complex
  - PI(4,5)P2
  - 'PSMA5 '
  - 'PSMA8 '
  - 'IGLV2-18(1-?) '
  - 'p-Y551-BTK '
  - SYK/FYN
  - DAG:p-5Y-PKC-theta:CBM oligomer:TRAF6
  - 'IGLV5-45(1-?) '
  - 'Ig lambda chain V-I region HA '
  - 'PSMD13 '
  - 'SHFM1 '
  - GADS:SLP76
  - 'IGLC1 '
  - 'p-4Y-PLCG2 '
  - PIP3 activates AKT
  - 'p-Y91,Y420-TXK '
  - 'IGLC3 '
  - PIP3, PI(3,4)P2
  - 'IGKV2D-30 '
  - 'PI(3,4)P2 '
  - LAT2
  - 'PIK3R2 '
  - 'IGLV(23-?) '
  - 'Ig lambda chain V-VI region AR '
  - 'PSMD4 '
  - 'K48PolyUb-K21,22-p-S32,S36-IkBA '
  - p-S63,S73-JUN
  - 'PSME2 '
  - 'VAV2 '
  - 'Ig lambda chain V-III region SH '
  - p-5Y-PKC-theta:DAG
  - complex
  - 'Ig lambda chain V-III region LOI '
  - RasGRPs:DAG:Ca2+
  - 'IKBKG '
  - 'PPP3CB '
  - 'Ig lambda chain V-I region NEWM '
  - Pi
  - 'p-Y223,Y551-BTK '
  - DAG
  - 'VAV1 '
  - 'PSMA7 '
  - 'MS4A2 '
  - 'Ig kappa chain V-I region Wes '
  - 'FCER1A '
  - 'Ig heavy chain V-III region CAM '
  - 'MyrG-p-Y420-FYN '
  - 'PSMD6 '
  - 'RAC1 '
  - 'p-FCERI aggregate '
  - 'p-S265-NFATC3 '
  - p-2S-cJUN:p-2S,2T-cFOS
  - 'TRAF6 '
  - p-SHC1:GRB2:SOS
  - 'Ig kappa chain V region EV15 '
  - AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramer
  - 'PSMB11 '
  - DAG:p-5Y-PKC-theta:p-S552,S645-CARMA1
  - MAP2K4
  - 'Ig heavy chain V-III region TRO '
  - Ca2+
  - 'MAPK10 '
  - 'Ig heavy chain V-II region MCE '
  - RAC1:GDP
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:VAV:p-2Y-BTK/p-2Y-ITK:PIP3
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG
  - 'PSMD8 '
  - conformation
  - 'IGKV4-1(21-?) '
  - 'NFKB1(1-433) '
  - 'CHUK '
  - 'p-Y519-TEC '
  - 'IGLC2 '
  - p-5Y-LAT:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:PIP3:p-VAV:RAC1-GTP
  - 'BTK '
  - 'Ig heavy chain V-I region EU '
  - 'p-S32,S36-NFKBIA '
  - 'Ub-48-UBC(1-76) '
  - TAB1:TAB2,TAB3:TAK1
  - 'TAB2 '
  - 'PSME4 '
  - 'Ig lambda chain V-IV region Kern '
  - 'IGLV1-36(1-?) '
  - 'p-Y174-VAV1 '
  - 'IGLV3-12(1-?) '
  - 'Ig kappa chain V-I region DEE '
  - p-T1400,T1412-MAP3K1
  - 'Ig lambda chain V-II region MGC '
  - 'Fe3+ '
  - PPi
  - GDP
  - 'Ig heavy chain V-III region KOL '
  - 'p-T183,Y185-MAPK9 '
  - 'PSMD1 '
  - 'Ub-504-UBC(457-532) '
  - ADP
  - cascade
  - 'Ub-124-UBC(77-152) '
  - MAP3K1
  - PDPK1
  - 'Ig kappa chain V-I region BAN '
  - 'PSMA6 '
  - 'GRAP2 '
  - 'TAB3 '
  - VAV1,2,3
  - 'PSMA3 '
  - PI3K
  - p-NFATC1,2,3
  - 'Ig kappa chain V-I region AU '
  - p-T,Y MAPK dimers
  - 'Ig lambda chain V-II region NEI '
  - MALT1
  - CHUK:IKBKB:IKBKG
  - 'PSMB8 '
  - 'p-Y90-PRKCQ '
  - 'Ig lambda chain V-IV region Hil '
  - 'p-12S-NFATC1 '
  - 'SOS1 '
  - 'Ig heavy chain V-II region NEWM '
  - p-Y239,Y240,Y317-SHC1-2
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:VAV:p-2Y-TEC kinases
  - 'VAV3 '
  - 'TEC '
  - 26S proteasome
  - p-10Y-NTAL:p-SHC1:GRB2:SOS:p-3Y-GAB2:PI3K
  - 'Ig heavy chain V-III region JON '
  - PRKQC closed
  - 'UBE2V1 '
  - MAPK8,9,10
  - 'Ig heavy chain V-II region WAH '
  - 'Ub-580-UBC(533-608) '
  - 'PSMF1 '
  - 'Ig kappa chain V-II region RPMI 6410 '
  - 'IGHE '
  - 'IgH  heavy chain V-III region VH26 precursor '
  - 'p-6Y-SYK '
  - 'RASGRP1 '
  - 'Ub-48-RPS27A(1-76) '
  - 'IGLV3-27(1-?) '
  - MAP2K7
  - ITPR:I(1,4,5)P3
  - 'RELA '
  - p-S177,S181-IKKB:IKKA:NEMO
  - 'BTRC '
  - 'PSMD10 '
  - 'p-Y173-VAV3 '
  - p:LYN:p-FCERI:IgE:allergin:SYK
  - 'PSMD9 '
  - 'NAD+ '
  - DAG:p-5Y-PKC-theta:CBM complex
  - Calcineurin:Calmodulin (CaN:CaM)
  - 'p-S177,S181-IKBKB '
  - p-SYK/p-BTK
  - 'PSMC3 '
  - GTP
  - p-T325,T331,S362,S374-FOS
  - 'S-Farn-Me-2xPalmS HRAS '
  - 'PPP3R1 '
  - BCL10
  - 'PIK3CA '
  - 'UBE2D2 '
  - 'p-T325,T331,S362,S374-FOS '
  - 'IGHV1-2 '
  - 'p-T185,Y187-MAPK1 '
  - 'IGKV2-28 '
  - 'UBE2N '
  - 'p-Y172-VAV2 '
  - 'IGKC '
  - 'CALM1 '
  - K63polyUb
  - GRB2-1:SOS1
  - 'IGLV7-43(1-?) '
  - 'IGLV4-60(1-?) '
  - 'PSMA4 '
  - JUN
  - 'PIK3CB '
  - 'p-10Y-LAT2 '
  - 'p-Y396-LYN '
  - 'S-Farn-Me KRAS4B '
  - p-S271,T275-MAP2K7
  - K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complex
  - 'Ig lambda chain V-I region VOR '
  - LYN
  - 'PSMB1 '
  - 'MAP3K7 '
  - 'IGLV2-11(1-?) '
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:VAV
  - 'IGLV2-23(1-?) '
  - 'PSMC2 '
  - 'PSMB3 '
  - Allergin
  - p-10Y-LAT2
  - p-2Y-PAK
  - 'PSMA1 '
  - 'TRAF6 oligomer '
  - p21 RAS:GDP
  - FCERI:IgE:allergin
  - 'IGLV11-55(1-?) '
  - 'Ig kappa chain V-III region VG '
  - p-S552,S645-CARD11
  - 'PSMC6 '
  - 'IKBKB '
  - 'IGLV1-44(1-?) '
  - SHC1-2
  - 'ITPR2 '
  - 'FCER1G '
  - 'p-5Y-LAT-2 '
  - PLC gamma1,2
  - 'RASGRP2 '
  - 'IGLV5-37(1-?) '
  - 'PSMB2 '
  - 'p-T221,Y223-MAPK10 '
  - 'p-Y113,128,145-LCP2 '
  - SCF-beta-TRCP
  - signaling
  - 'DAGs '
  - p:LYN:p-FCERI:IgE:allergin:p-6Y-SYK
  - 'Allergin '
  - UBE2N:UBE2V1
  - 'p-Y206,Y519-TEC '
  - 'p-S257-NFATC1 '
  - H2O
  - 'PAK2 '
  - 'p-BCL10 '
  - 'IGLV3-16(1-?) '
  - 'TXK '
  - 'PSMC4 '
  - 'IGHV7-81(1-?) '
  - TRAF6
  - I(1,4,5)P3
  - 'PRKCQ '
  - CALM1:4xCa2+
  - 'Ig heavy chain V-III region DOB '
  - DAG:p-5Y-PKC-theta:CBM oligomer
  - 'AHCYL1 '
  - tetramer
  - p-10Y-NTAL:p-SHC1:GRB2:SOS:GAB2
  - 'PLCG2 '
  - 'CUL1 '
  - 'Ub-352-UBC(305-380) '
  - 'p-S271,T275-MAP2K7 '
  - 'Ig kappa chain V-I region Gal '
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:VAV:TEC kinases:PIP3
  - 'IGKVA18(21-?) '
  - 'PSMD5 '
  - 'PSMD2 '
  - 'Ig heavy chain V-II region OU '
  - 'UBE2D1 '
  - 'PLCG1 '
  - 'PSMD7 '
  - 'PSMC5 '
  - 'p-CARMA1 oligomer '
  - 'PSME1 '
  - 'MALT1 '
  - 'Ub-200-UBC(153-228) '
  - PI(3,4,5)P3
  - 'PDPK1 '
  - 'PPP3CA '
  - 'PSMD3 '
  - AMP
  - 'IGKV1-12 '
  - RAF/MAP kinase
  - 'BCL10 oligomer '
  - p-10Y-NTAL:p-SHC1:GRB2:SOS
  - 'Ig kappa chain V-I region HK101 '
  - 'FCERI:IgE aggregate '
  - 'FBXW11 '
  - 'ITPR3 '
  - 'Ig kappa chain V-III region B6 '
  - 'PAK1 '
  - DAG:p-5Y-PKC-theta:CBM oligomer:TRAF6 oligomer
  - 'IGLV4-69(1-?) '
  - Allergin:p-LYN:p-FCERI:IgE aggregate
  - 'SYK '
  - 'I(1,4,5)P3 '
  - 'p-Y420-TXK '
  - 'Ig heavy chain V-II region ARH-77 '
  - UBE2D2,UBE2D1,(CDC34)
  - 'p-T,Y-MAPK8 '
  - 'CDC34 '
  - 'Ig lambda chain V region 4A '
  - 'IGKV3D-20 '
  - p-MAP2K4/p-MAP2K7
  - 'PSMB6 '
  - 'Ig kappa chain V-II region FR '
  - 'IGLC6 '
  - 'Ub-428-UBC(381-456) '
  - 'p-S552,S645-CARD11 '
  - CARD11
  - p-MAPK8,9,10
  - GAB2
  - p-5Y-LAT:p-SHC1:GRB2:SOS1
  - bound to CBM
  - p-5Y-LAT:p-SHC1:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:VAV:p-TEC kinases:PIP3
  - 'Ub-48-UBB(1-76) '
  - 'p-4Y-PLCG1 '
  - 'MALT1 oligomer '
  - 'PSMB10 '
  - 'PSMD11 '
  - p-5Y-LAT:GRB2:SOS1:GADS:p-Y113,Y128,Y145-SLP-76:PLCG1:PIP3:p-VAV
  - LAT-2
  - FOS
  - 'Ig heavy chain V-I region HG3 '
  - 'IGLV4-3(1-?) '
  - 'Ig lambda chain V-IV region Bau '
  - 'Ig lambda chain V-II region TOG '
  - 'NFKBIA '
  - p-S177,S181-IKKB:IKKA:pUb-NEMO
  - 'S-Farn-Me-PalmS KRAS4A '
  - 'Ub-276-UBC(229-304) '
  - 'Ig kappa chain V-I region AG '
  - p-S257,T261-MAP2K4
  - 'PSMC1 '
  - 'PI(3,4,5)P3 '
  - p-10Y-NTAL:p-SHC1:GRB2:SOS:p-3Y-GAB2
  - homotetramer
  - 'p-T202,Y204-MAPK3 '
  - p-5Y-LAT-2
  - Calcineurin (CaN)
  - 'PSME3 '
  - p-Y90-PKC-theta:DAG
  - ATP
  license: CC0
  name: Fc epsilon receptor (FCERI) signaling
seo: CreativeWork
title: Fc epsilon receptor (FCERI) signaling
wpid: WP2759
---